US FDA chief discusses co-operation and staff visas during China visit
This article was originally published in SRA
Executive Summary
Co-operation with China is a key issue for US Food and Drug Administration Commissioner Margaret Hamburg – so much so that she used the word eight times during a 17 November address at Peking University in Bejing on the first day of her visit there this week.